Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$115M |
| 2 |
Apple
AAPL
|
+$95.4M |
| 3 |
DXC Technology
DXC
|
+$91M |
| 4 |
Pfizer
PFE
|
+$66.9M |
| 5 |
Johnson & Johnson
JNJ
|
+$60.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$121M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$51.9M |
| 3 |
HP
HPQ
|
+$50.3M |
| 4 |
HOLX
Hologic
HOLX
|
+$45M |
| 5 |
Carlisle Companies
CSL
|
+$36.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.17% |
| 4 | Industrials | 11.08% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
TTEC Holdings
TTEC
$124M
| $3.25M | ﹤0.01% |
79,729
-3,713
| -4% | -$135K |
|
|
SPPI
2027
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.24M | ﹤0.01% |
435,422
-110,588
| -20% | -$723K |
|
|
BRSL
2028
Brightstar Lottery PLC
BRSL
$2.03B
| $3.24M | ﹤0.01% |
177,045
-138,197
| -44% | -$2.83M |
|
2029
US Physical Therapy
USPH
$1.22B
| $3.24M | ﹤0.01% |
53,637
+541
| +1% | +$34.6K |
|
|
MBLY
2030
DELISTED
Mobileye N.V.
MBLY
| $3.23M | ﹤0.01% |
51,481
+7,089
| +16% | +$440K |
|
|
CNR
2031
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $3.23M | ﹤0.01% |
193,464
+28,607
| +17% | +$485K |
|
2032
LGI Homes
LGIH
$1.4B
| $3.23M | ﹤0.01% |
80,279
+14,002
| +21% | +$470K |
|
|
MCRN
2033
DELISTED
Milacron Holdings Corp.
MCRN
| $3.22M | ﹤0.01% |
182,957
+104,733
| +134% | +$1.88M |
|
2034
MGP Ingredients
MGPI
$375M
| $3.21M | ﹤0.01% |
62,828
+4,079
| +7% | +$213K |
|
|
OMN
2035
DELISTED
OMNOVA Solutions Inc.
OMN
| $3.21M | ﹤0.01% |
329,534
-105,678
| -24% | -$955K |
|
|
AXDX
2036
DELISTED
Accelerate Diagnostics
AXDX
| $3.21M | ﹤0.01% |
11,724
+793
| +7% | +$215K |
|
|
FLIC
2037
DELISTED
First of Long Island Corp
FLIC
| $3.21M | ﹤0.01% |
112,128
+12,288
| +12% | +$337K |
|
2038
Coca-Cola Europacific Partners
CCEP
$47.9B
| $3.21M | ﹤0.01% |
78,781
+23,830
| +43% | +$943K |
|
2039
Baidu
BIDU
$37.2B
| $3.2M | ﹤0.01% |
17,872
+6,246
| +54% | +$1.13M |
|
|
KERX
2040
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.19M | ﹤0.01% |
441,106
+4,388
| +1% | +$27.4K |
|
2041
Lexicon Pharmaceuticals
LXRX
$1.1B
| $3.18M | ﹤0.01% |
193,318
+1,633
| +0.9% | +$25.3K |
|
|
BMTC
2042
DELISTED
Bryn Mawr Bank Corp
BMTC
| $3.18M | ﹤0.01% |
74,842
+930
| +1% | +$38.4K |
|
|
CPL
2043
DELISTED
CPFL Energia S.A.
CPL
| $3.17M | ﹤0.01% |
198,560
+71,183
| +56% | +$1.15M |
|
|
ESPR
2044
DELISTED
Esperion Therapeutics
ESPR
| $3.16M | ﹤0.01% |
68,275
+13,146
| +24% | +$483K |
|
2045
ICICI Bank
IBN
$108B
| $3.16M | ﹤0.01% |
351,865
+79,983
| +29% | +$676K |
|
|
GTY
2046
Getty Realty Corp
GTY
$2.07B
| $3.15M | ﹤0.01% |
125,508
+8,687
| +7% | +$223K |
|
|
SYNT
2047
DELISTED
Syntel Inc
SYNT
| $3.15M | ﹤0.01% |
185,679
+36,423
| +24% | +$632K |
|
|
HDP
2048
DELISTED
Hortonworks, Inc.
HDP
| $3.15M | ﹤0.01% |
244,427
+39,395
| +19% | +$473K |
|
2049
Columbus McKinnon
CMCO
$584M
| $3.15M | ﹤0.01% |
123,828
+2,900
| +2% | +$75.1K |
|
2050
Center Bancorp
CNOB
$1.78B
| $3.15M | ﹤0.01% |
139,592
+28,064
| +25% | +$640K |
|
Similar funds
Charles Schwab's Q2 2017 Portfolio in Review
As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.
- Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
- Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
- Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
- Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
- Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
- Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
- Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.
Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.